Prosthetic valve support structure

Information

  • Patent Grant
  • 10835376
  • Patent Number
    10,835,376
  • Date Filed
    Monday, February 12, 2018
    6 years ago
  • Date Issued
    Tuesday, November 17, 2020
    3 years ago
Abstract
The present invention is directed to prostheses including a support structure having a proximal end and a distal end, and a motion limiting member attached to the distal end of the support structure, wherein the motion limiting member is configured to restrict radial expansion of the distal end of the support structure. Methods for delivering the prosthesis are also provided.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

The present invention relates to prosthetic valves and methods for their implantation. More particularly, the present invention provides for prosthetic valve support structures configured for transcatheter delivery.


Background

Aortic valve replacement in patients with severe valve disease is a common surgical procedure. The replacement is conventionally performed by open heart surgery, in which the heart is usually arrested and the patient is placed on a heart bypass machine. Prostheses including prosthetic heart valves have been developed that are implanted using minimally invasive procedures such as transapical or percutaneous approaches. These methods involve compressing the prosthesis radially to reduce its diameter, inserting the prosthesis into a delivery tool, such as a catheter, and advancing the delivery tool to the correct anatomical position in the heart. Once properly positioned, the prosthesis is deployed by radial expansion within the native valve annulus.


Such a prosthesis can include a support structure to maintain the prosthetic heart valve in place. The inflow section of the prosthesis can be subject to radial interference from a body lumen, such as the left ventricular outflow tract (LVOT), that can exert circumferential radial pressure on the prosthesis. Such radial interference at an inflow section of the prosthesis can result in radial movement at an outflow section of the prosthesis. Such movement may be undesirable.


Moreover, a prosthesis can be subject to radial movement at an inflow section, due to, for example, valve function and cardiac contraction. Such radial movement can cause the diameter of the inflow section to experience cyclical contraction and expansion. Such contraction and expansion can subject the prosthesis to unnecessary fatigue.


Additionally, due to less than perfect conformance between the geometries of a patient's anatomy and the prosthesis, paravalvular leakage can occur. For example, a major course of leakage between a prosthesis and the LVOT wall is due to spaces created between scalloped leaflets called inter-leaflet triangles.


Accordingly, there is a need for a prosthesis that provides decoupled radial motion of the outflow section and the inflow section, and that better conforms to a patient's anatomy.


PCT Publication No. WO 05/002466 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes prosthetic devices for treating aortic stenosis.


PCT Publication No. WO 06/070372 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes a prosthetic device having a single flow field therethrough, adapted for implantation in a subject, and shaped so as to define a fluid inlet, and a diverging section, distal to the fluid inlet.


US Patent Application Publication No. 2006/0149360 to Schwammenthal et al., which is incorporated herein by reference in its entirety, describes a prosthetic device including a valve-orifice attachment member attachable to a valve in a blood vessel and including a fluid inlet, and a diverging member that extends from the fluid inlet, the diverging member including a proximal end near the fluid inlet and a distal end distanced from the proximal end. A distal portion of the diverging member has a larger cross-sectional area for fluid flow therethrough than a proximal portion thereof.


US Patent Application Publication No. 2006/0259136 to Nguyen et al., which is incorporated herein by reference, describes a heart valve prosthesis having a self-expanding multi-level frame that supports a valve body including a skirt and plurality of coapting leaflets. The frame transitions between a contracted delivery configuration that enables percutaneous transluminal delivery, and an expanded deployed configuration having an asymmetric hourglass shape. The valve body skirt and leaflets are constructed so that the center of coaptation can be selected to reduce horizontal forces applied to the commissures of the valve, and to efficiently distribute and transmit forces along the leaflets and to the frame. Alternatively, the valve body can be used as a surgically implantable replacement valve prosthesis.


BRIEF SUMMARY OF THE INVENTION

The present invention provides a valve prosthesis support structure that limits radial motion at a distal end thereof.


The present invention also provides a valve prosthesis support structure that limits radial motion at a proximal end thereof.


The present invention also provides a valve prosthesis support structure that includes sealing members to prevent paravalvular leakage.


The present invention provides a prosthesis including a support structure having a proximal end and a distal end, and a motion limiting member attached to the distal end of the support structure, wherein the motion limiting member is configured to restrict radial expansion of the distal end of the support structure.


The present invention also provides a valve prosthesis support structure, including a collapsible and expandable support structure including a plurality of posts at a distal end thereof and a flared portion extending in a proximal direction from the plurality of posts, and a motion limiting member attached to a proximal end of the proximal skirt, wherein the motion limiting member is configured to restrict radial movement of the proximal end of the collapsible support structure.


The present invention also provides a method of delivering a prosthesis to a desired location in a body. One such method includes introducing a sheath of a delivery system into a subject's vasculature, wherein a distal tip of the sheath contains the prosthesis, advancing the distal tip of the sheath to the desired location in the body, and releasing the prosthesis within the body, wherein the prosthesis includes a support structure having a proximal end and a distal end, and a motion limiting member attached to the distal end of the support structure.


Additional features of the invention will be set forth in the description that follows. Both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying figures, which are incorporated herein, form part of the specification and illustrate exemplary embodiments of the present invention. Together with the description, the figures further serve to explain the principles of and to enable a person skilled in the relevant art(s) to make and use the exemplary embodiments described herein. In the drawings like reference characters indicate identical or functionally similar elements.



FIG. 1 is a perspective view of a valve prosthesis subject to radial interference at a proximal end.



FIG. 2 is a perspective view of a valve prosthesis not subject to radial interference at a proximal end.



FIG. 3 is a perspective view of a valve prosthesis according to an embodiment of the present invention.



FIG. 4 is a top schematic view of the valve prosthesis of FIG. 3.



FIG. 5 is a perspective view of a valve prosthesis according to an embodiment of the present invention.



FIG. 6 is a side schematic view of the valve prosthesis of FIG. 5.



FIG. 7 is a perspective view of a valve prosthesis according to an embodiment of the present invention.



FIG. 8 is a top schematic view of the valve prosthesis of FIG. 7.



FIG. 9 is a perspective view of a valve prosthesis according to an embodiment of the present invention.



FIG. 10 is a side schematic view of the valve prosthesis of FIG. 10.



FIG. 11 is a perspective view of a valve prosthesis according to an embodiment of the present invention.



FIG. 12 is a perspective view of a valve prosthesis according to an embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The following detailed description of the present invention refers to the accompanying figures that illustrate exemplary embodiments. Other embodiments are possible and may fall within the scope of the present invention. Modifications can be made to the exemplary embodiments described herein without departing from the spirit and scope of the present invention. Therefore, the following detailed description is not meant to be limiting. The operation and behavior of the exemplary embodiments presented are described with the understanding that various modifications and variations of the exemplary embodiments may be within the scope of the present invention.



FIG. 1 is a perspective view of a valve prosthesis 100 subject to radial interference at a proximal end. Radial interference can constrain or cause a change in the diameter of a portion of valve prosthesis 100. FIG. 2 is a perspective view of valve prosthesis 100 not subject to radial interference at a proximal end. Valve prosthesis 100 includes an inflow section 110 at a proximal end thereof, and an outflow section 120 at a distal end thereof. Valve prosthesis 100 also includes a valve prosthesis support structure 130.


Valve prosthesis support structure 130 includes posts 122 (also referred to as commissural posts) proximate to outflow section 120, and a proximal skirt 132 extending from inflow section 110 toward posts 122.


Valve prosthesis 100 is preferably collapsible in order to facilitate transcatheter delivery. Preferably, valve prosthesis 100 can be delivered via a transfemoral approach. Valve prosthesis 100 can also be delivered, however, by other transvascular approach methods or a transapical approach. Valve prosthesis 100 can also be implanted by open heart surgery or related methods. The valve prosthesis 100 can expand radially upon delivery at a target site. The target site is preferably the native aortic annulus of a subject, but it is understood that valves according to the present invention could be implanted at other positions in a subject (e.g., a native mitral or pulmonary annulus).


For example, distal tip of a catheter sheath containing prosthesis 100 can be inserted into a patient's vasculature (e.g., via a body lumen such as a femoral artery) and advanced (along a guide wire, if provided) to the position of a native annulus. The native leaflets of the annulus can be in place at the time of implantation of prosthesis 100, or can be partially or completely removed prior to implantation. An outer tube of the catheter can be withdrawn some distance to expose a proximal portion of proximal skirt 132. The proximal portion can be positioned so as to abut against the ventricular side of the aortic annulus. If provided, barbs 134 can be primary contact points of prosthesis 100 with an interior of a valve retaining sleeve, thereby reducing friction that could be caused by the inner surface of the valve retaining sleeve sliding over prosthesis 100 while prosthesis 100 moves with respect to the catheter sheath. Once it is determined that prosthesis 100 is properly positioned in the annulus, the outer tube can be fully withdrawn, releasing valve prosthesis 100 and allowing radial expansion of valve prosthesis 100 to engage the annulus. If, after partial release, it is determined that the prosthesis is not properly positioned, the inflow section 110 can be recaptured into the outer tube for repositioning.


Prosthesis support structure 130 can be made of a self-expanding material, e.g., nitinol, thus tending toward a fully expanded position that is sufficient to securely engage the native annulus. When in position within a patient, this tendency creates a radial force between prosthesis support structure 130 and the patient's anatomy, thus helping to hold valve prosthesis 100 in place. The pressure applied by the prosthesis support structure 130, however, need not be sufficient by itself to anchor the prosthesis 100 in the native annulus. Further inhibiting migration of valve prosthesis 100 can be axial support arms 128, which protrude over the tips of the native leaflets to provide axial support to valve prosthesis 100 and to prevent valve prosthesis 100 from being forced into the ventricle through the native leaflets during the cardiac cycle. Support arms 128 can take on a variety of configurations. Further, as detailed above, inflow section 110 can engage the ventricle below the inflow end of the native annulus, providing additional anchoring.


Support arms 128 can, for example, be configured to be at least partially disposed within aortic sinuses of the subject, and, for some applications, to engage and/or rest against floors of the aortic sinuses, and to apply an axial force directed toward a left ventricle of the subject. Support arms 128 can meet one another at junctures. For applications in which each of support arms 128 is fabricated as a separate piece, the support arms can be mechanically engaged to one another where they meet at the junctures. For some applications, support arms 128 meet one another without actually touching one another, and instead meet via an area defined at each juncture. Typically, the support arms are configured to define peaks at the junctures, and troughs between adjacent peaks. U.S. application Ser. No. 11/728,253, filed Mar. 23, 2007, and U.S. application Ser. No. 11/726,889, filed Mar. 23, 2007 detail various support arm configurations, and each is incorporated by reference herein in its entirety.


In some exemplary embodiments, valve prosthesis 100 includes three posts 122, arranged circumferentially around a central longitudinal axis of valve prosthesis 100, and a flared portion extending in a proximal direction from posts 122. In some exemplary embodiments, valve prosthesis 100 includes more or fewer than three posts 122, such as, for example, two posts 122, or four posts 122. Approximately 90% of humans have exactly three aortic sinuses. The three posts 122 provided in some exemplary embodiments correspond to these three aortic sinuses. For implantation in the approximately 10% of patients that have exactly two aortic sinuses, valve prosthesis 100 can include only two posts 122.


Valve prosthesis 100 can also include a valve 150 coupled to posts 122. Valve 150 can be formed of a pliant material configured to collapse inwardly (i.e., towards the central longitudinal axis of valve prosthesis 100) during diastole, in order to inhibit retrograde blood flow, and to open outwardly during systole, to allow blood flow through valve prosthesis 100. Valve 150 can be formed of artificial or natural tissue. For example, valve 150 can be formed of bovine or porcine pericardium, or of any suitable synthetic material.



FIG. 2 is a perspective view of valve prosthesis 100 in an expanded state, wherein no inward radial pressure or interference is applied to inflow section 110. In this expanded state, inflow section 110 has a diameter ID2, and outflow section 120 has an outflow diameter OD2. FIG. 1 is a perspective view of a valve prosthesis 100 that is subject to inward radial pressure or interference at inflow section 110. Depending on the geometry of a particular subject's annulus, inflow section 110 will often be in at least a somewhat compressed position as shown in FIG. 1 due to the radial interference at inflow section 110. In this position, outflow section 120 has an outflow diameter OD1 that is larger than OD2, causing posts 122 to be positioned farther from one another than in a relaxed state. In other words, the outflow diameter of valve prosthesis 100 at outflow section 120 and the positioning of posts 122 are affected by radial interference on valve prosthesis 100 at inflow section 110, which can result in decreased performance characteristics of valve prosthesis 100.


Decoupling of radial motion of outflow section 120 from radial interference at inflow section 110 can produce significant benefits by providing more predictable and stable valve geometry regardless of patient-specific anatomy.



FIG. 3 is a perspective view of a valve prosthesis 300 according to an embodiment of the present invention. FIG. 4 is a top schematic view of valve prosthesis 300. The basic structure of valve prosthesis 300 is generally similar to valve prosthesis 100. Valve prosthesis 300 includes an inflow section 310 at a proximal end thereof, and an outflow section 320 at a distal end thereof. Valve prosthesis support structure 330 includes posts 322 proximate to outflow section 320, and a proximal skirt 332 extending from inflow section 310 towards posts 322. Valve prosthesis 300 also includes a valve prosthesis support structure 330.


Valve prosthesis 300 further includes a motion limiting member 324. Motion limiting member 324 includes a substantially rigid circular frame disposed around outflow section 320. The substantially rigid circular frame preferably substantially maintains its shape even when subjected to outside forces such as can be present within a body lumen of a patient. The substantially rigid circular frame can be made of, for example, the types of surgical steel traditionally used for making stent devices. Motion limiting member 324 can be mounted to valve prosthesis support structure 330 by being attached to distal ends of posts 322. In such a configuration, motion limiting member 324 prevents divergence of posts 322 by limiting the maximum diameter of outflow section 320, thereby preventing motion of posts 322 beyond the limits imposed by motion limiting member 324. Motion limiting member 324 can be constructed of a variety of materials, for example, nitinol.


The rigid circular frame of motion limiting member 324 can, however, be sufficiently flexible to be compatible with collapse of valve prosthesis 300 during an insertion process.


The rigid circular frame of motion limiting member 324 can alternately or additionally be mounted to valve prosthesis support structure 330 by being attached to proximal ends of posts 322, or at intermediate positions of posts 322, in between proximal and distal ends.


Because the diameter of outflow section 320 is limited by motion limiting member 324, the diameter of outflow section 320 is not substantially affected by changes in the diameter of inflow section 310, thereby decoupling radial motion of outflow section 320 from radial interference at inflow section 310. Thus, valve prosthesis 300 maintains predictable and stable valve geometry regardless of patient-specific anatomy.



FIG. 5 is a perspective view of a valve prosthesis 500 according to an exemplary embodiment of the present invention. FIG. 6 is a side schematic view of valve prosthesis 500. Description of elements of the embodiment depicted in FIGS. 5 and 6 that are the same or operate similarly as the embodiments described above may be omitted or abbreviated.


Valve prosthesis 500 includes an inflow section 510 at a proximal end thereof, and an outflow section 520 at a distal end thereof. Valve prosthesis 500 also includes a valve prosthesis support structure 530, and a motion limiting member 524. Valve prosthesis support structure 530 includes posts 522 proximate to outflow section 520, and a proximal skirt 532 extending from inflow section 510 toward posts 522.


Motion limiting member 524 includes rigid arches disposed proximate to outflow section 520. Each rigid arch is mounted to valve prosthesis support structure 530 by being attached to proximal ends of two adjacent posts 522. In this way, the rigid arches of the motion limiting member 524 together extend around outflow section 520. In such a configuration, motion limiting member 524 prevents divergence of posts 522 by limiting the diameter of outflow section 520, thereby preventing motion of posts 522 beyond the limits imposed by motion limiting member 524.


In some embodiments, the rigid arches of motion limiting member 524 can together form a circular shape, or can form another shape, such as, for example, a series of linked “humps” connecting around outflow section 520.


In some embodiments, the rigid arches of motion limiting member 524 are sufficiently flexible to collapse with valve prosthesis 500 during an insertion process.


In some embodiments, the rigid arches of motion limiting member 524 are mounted to valve prosthesis support structure 530 by being attached to distal ends of posts 522, or at intermediate positions of posts 522, in between proximal and distal ends.


In some embodiments, the rigid arches of motion limiting member 524 can extend out from valve prosthesis support structure 530 at a 90 degree angle with respect to a longitudinal axis extending through valve prosthesis 500. Alternatively, the rigid arches of motion limiting member 524 can extend from valve prosthesis support structure 530 at an angle other than 90 degrees, such as, for example, approximately 30 degrees, approximately 45 degrees, or approximately 120 degrees. Moreover, each rigid arch need not extend out from valve prosthesis support structure 530 at the same angle as other rigid arches.


In some embodiments multiple rigid arches can extend between adjacent posts 522. Intermediate connections can be formed between adjacent rigid arches such that the rigid arches extending between adjacent posts 522 are connected in series.


Because the diameter of outflow section 520 is limited by motion limiting member 524, it is not substantially affected by radial interference (i.e., changes in diameter) at inflow section 510, thereby achieving decoupling of radial motion of outflow section 520 from radial interference at inflow section 510. Thus, valve prosthesis 500 maintains predictable and stable valve geometry regardless of patient-specific anatomy.



FIG. 7 is a perspective view of a valve prosthesis 700 according to an embodiment of the present invention. FIG. 8 is a side schematic view of valve prosthesis 700. Description of elements of the embodiment depicted in FIGS. 7 and 8 that are the same or operate similarly as the embodiments described above may be omitted or abbreviated.


Valve prosthesis 700 includes an inflow section 710 at a proximal end thereof, and an outflow section 720 at a distal end thereof. Valve prosthesis 700 also includes a valve prosthesis support structure 730, and a motion limiting member 724.


Valve prosthesis support structure 730 includes posts 722 proximate to outflow section 720, and a proximal skirt 732 extending from posts 722 toward inflow section 710.


Motion limiting member 724 includes linear support elements disposed proximate to outflow section 720. Each linear support element is mounted to valve prosthesis support structure 730 by being attached to distal ends of two adjacent posts 722. In this way, the linear support elements of motion limiting member 724 together link posts 722. In such a configuration, motion limiting member 724 prevents divergence of posts 722 by limiting the diameter of outflow section 720, thereby preventing motion of posts 722 beyond the limits imposed by motion limiting member 724.


In some embodiments the linear support elements of motion limiting member 724 are non-rigid and act only in tension. For example, such linear support elements can be made of string, wire, sutures, or the like.


In some embodiments, the linear support elements of motion limiting member 724 are rigid.


In some embodiments, the linear support elements of motion limiting member 724 are mounted to valve prosthesis support structure 730 by being attached to proximal ends of posts 722, or at intermediate positions of posts 722, in between proximal and distal ends.


In some embodiments multiple linear support sub-elements can extend between adjacent posts 722, with intermediate connections between adjacent linear support sub-elements such that the linear support sub-elements extending between adjacent posts 722 are connected in series.


Because the diameter of outflow section 720 is limited by motion limiting member 724, it is preferably not substantially affected by radial interference (i.e., changes in diameter) at inflow section 710, thereby achieving decoupling of radial motion of outflow section 720 from radial interference at inflow section 710. Thus, valve prosthesis 700 maintains predictable and stable valve geometry regardless of patient-specific anatomy.



FIG. 9 is a perspective view of a valve prosthesis 900 according to an embodiment of the present invention. FIG. 10 is a side schematic view of valve prosthesis 900. Description of elements of the embodiment depicted in FIGS. 9 and 10 that are the same or operate similarly as the embodiments described above may be omitted or abbreviated.


Valve prosthesis 900 includes an inflow section 910 at a proximal end thereof, and an outflow section 920 at a distal end thereof. Valve prosthesis 900 also includes a valve prosthesis support structure 930, and a motion limiting member 926.


Valve prosthesis support structure 930 includes posts 922 proximate to outflow section 920, and a proximal skirt 932 extending from inflow section 910 toward posts 922.


Motion limiting member 926 includes strut support elements disposed proximate to inflow section 910. Each strut support element is mounted to a proximal end of inflow section 910, and extends between adjacent endpoints of proximal skirt 932. In this way, the strut support elements of motion limiting member 926 together link endpoints of inflow section 910. In such a configuration, motion limiting member 926 prevents divergence of the endpoints of proximal skirt 932 by limiting the diameter of inflow section 910, thereby preventing motion of the endpoints of proximal skirt 932 beyond the limits imposed by motion limiting member 926.


In some embodiments, multiple strut support elements can extend between adjacent endpoints of proximal skirt 932, with intermediate connections between adjacent endpoints of proximal skirt 932 such that the strut support elements extending between adjacent endpoints of proximal skirt 932 are connected in series.


In some embodiments, the strut support members of motion limiting member 926 are incorporated in and form a part of proximal skirt 932 such that motion limiting member 926 and proximal skirt 932 are formed together monolithically.


In some embodiments, the strut support members of motion limiting member 926 are rigid. In some embodiments, the strut support members of motion limiting member are non-rigid.


Because the diameter of inflow section 910 is limited by motion limiting member 926, its motion due to valve function and cardiac contraction can be confined to within limits necessary for proper functioning, thereby eliminating or reducing unnecessary radial movement. Reducing this unnecessary radial movement in turn reduces the fatigue that valve prosthesis 900 is subject to, thereby extending its useful life, and eliminating the need for subsequent replacement of valve prosthesis 900 or reducing the frequency with which valve prosthesis 900 must be replaced to maintain proper functionality. Additionally, because motion limiting member 926 limits the diameter of inflow section 910, valve prosthesis 900 maintains more predictable and stable valve motion and valve geometry regardless of patient-specific anatomy. Further, stabilizing the diameter of inflow section 910 results in less deformation (i.e., changes in diameter) of outflow section 920.



FIG. 11 is a perspective view of a valve prosthesis 1100 according to an embodiment of the present invention. Description of elements of the embodiment depicted in FIG. 11 that are the same or operate similarly as those described above may be omitted or abbreviated.


Valve prosthesis 1100 includes an inflow section 1110 at a proximal end thereof, and an outflow section 1120 at a distal end thereof. Valve prosthesis 1100 also includes a valve prosthesis support structure 1130, and sealing members 1142.


Valve prosthesis support structure 1130 includes posts 1122 proximate to outflow section 1120, and a proximal skirt 1132 extending from posts 1122 toward inflow section 1110.


Sealing members 1142 can be disposed proximate to inflow section 1110, and can be positioned to correspond radially with posts 1122. Such positioning corresponds to native commissures, and aligns sealing members 1142 with a patient's inter-leaflet triangles. Sealing members 1142 can be shaped so as to fit into the inter-leaflet triangles, or can be formed of a material that conforms to the shape of the inter-leaflet triangles upon being placed in contact with the inter-leaflet triangles. In this way, sealing members 1142 help valve prosthesis 1100 attain a high level of conformance to the patient's annular anatomy, thereby preventing or reducing the chance and severity of paravalvular leakage. U.S. application Ser. No. 13/091,765, filed Apr. 21, 2011, discusses sealing members for use with prosthetic valves, and is incorporated by reference herein in its entirety.



FIG. 12 is a perspective view of a valve prosthesis 1200 according to an embodiment of the present invention. Description of elements of the embodiment depicted in FIG. 12 that are the same or operate similarly as those described above may be omitted or abbreviated.


Valve prosthesis 1200 includes an inflow section 1210 at a proximal end thereof, and an outflow section 1220 at a distal end thereof. Valve prosthesis 1200 also includes a valve prosthesis support structure 1230, and a sealing member 1242.


Valve prosthesis support structure 1230 includes posts 1222 proximate to outflow section 1220, and a proximal skirt 1232 extending from posts 1222 toward inflow section 1210.


Sealing member 1242 can be disposed proximate to inflow section 1210, and can extend around the circumference of proximal skirt 1232. Sealing member 1242 can include sealing tips 1244 positioned to correspond radially with posts 1222. Such positioning corresponds to native commissures, and aligns sealing tips 1244 with a patient's inter-leaflet triangles. Sealing tips 1244 can be shaped so as to fit into the inter-leaflet triangles, or can be formed of a material that conforms to the shape of the inter-leaflet triangles upon being placed in contact with the inter-leaflet triangles. In this way, sealing member 1242, including sealing tips 1244, helps valve prosthesis 1200 attain a high level of conformance to the patient's annular anatomy, thereby preventing or reducing the chance and severity of paravalvular leakage.


In some embodiments, sealing member 1242 including sealing tips 1244 is formed of a single material. In some embodiments, sealing tips 1244 are formed of a material different from the balance of sealing member 1242. For example, sealing tips 1244 can be faulted of a soft material capable of conforming to the patient's inter-leaflet triangles, while the balance of sealing member 1242 can be formed of a more rigid material.


In some embodiments, sealing member 1242 acts as a motion limiting member, and limits the diameter of inflow section 1210, thereby preventing motion of endpoints of proximal skirt 1232 beyond limits imposed by sealing member 1242. In this way, sealing member 1242 is similar to motion limiting member 926.


While various embodiments of the present invention have been described above, they have been presented by way of example only, and not limitation. The elements of the embodiments presented above are not necessarily mutually exclusive, but can be interchanged to meet various needs as would be appreciated by one of skill in the art.


It therefore will be apparent to one skilled in the art that various changes in form and detail can be made to the embodiments disclosed herein without departing from the spirit and scope of the present invention. The phraseology or terminology herein is used for description and not for limitation. Thus, it is intended that the present invention cover modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

Claims
  • 1. A prosthesis comprising: a support structure having a proximal portion and a distal portion, the support structure including a plurality of commissure posts at the distal portion;a valve coupled to the commissure posts; anda motion limiting member attached to the plurality of commissure posts,wherein, when deployed, the motion limiting member restricts radial expansion of the distal portion of the support structure,wherein the motion limiting member comprises a plurality of linear support elements, each linear support element extending between and having opposing ends attached to adjacent commissure posts of the plurality of commissure posts.
  • 2. The prosthesis of claim 1, wherein each linear support element is attached to distal ends of the adjacent commissure posts.
  • 3. The prosthesis of claim 1, wherein each linear support element is formed of a non-rigid material.
  • 4. The prosthesis of claim 1, wherein each linear support element is formed of a rigid material.
  • 5. The prosthesis of claim 1, wherein the motion limiting member is configured to limit radial movements of the plurality of commissure posts.
  • 6. The prosthesis of claim 1, further comprising a sealing member attached to the proximal portion of the support structure, wherein the sealing member is shaped and configured to conform to interleaflet triangles of a patient's heart.
  • 7. The prosthesis of claim 6, wherein the sealing member comprises a plurality of sealing elements, each sealing element being positioned so as to align with a corresponding commissure post of the plurality of commissure posts.
  • 8. The prosthesis of claim 6, wherein the sealing member extends around the proximal portion of the support structure.
  • 9. The prosthesis of claim 6, wherein the sealing member comprises a plurality of sealing tips, andwherein the sealing member is oriented so as to align each sealing tip with a corresponding post of the plurality of posts.
  • 10. A prosthesis, comprising: a collapsible and expandable support structure including a plurality of posts at a distal portion thereof and a flared portion extending in a proximal direction from the plurality of posts, the flared portion comprising a bulging proximal portion comprising a plurality of endpoints;a valve coupled to the support structure; anda motion limiting member attached to a proximal portion of the support structure, the motion limiting member comprising a plurality of struts, the plurality of struts linking adjacent endpoints,wherein the motion limiting member is configured to restrict radial movement of the proximal portion of the support structure.
  • 11. The prosthesis of claim 10, wherein a strut of the plurality of struts links adjacent endpoints.
  • 12. The prosthesis of claim 10, wherein a plurality of the plurality of struts link adjacent endpoints.
  • 13. The prosthesis of claim 10, wherein the motion limiting member is monolithic with the support structure.
  • 14. A prosthesis comprising: a collapsible and expandable support structure including a plurality of posts at a distal portion thereof and a flared portion extending in a proximal direction from the plurality of posts, the flared portion comprising a bulging proximal portion comprising a plurality of endpoints;a motion limiting member attached to a proximal portion of the support structure, the motion limiting member comprising a plurality of struts, the plurality of struts linking adjacent endpoints; anda sealing member attached to the support structure, wherein the sealing member is shaped and configured to conform to interleaflet triangles of a patient's heart,wherein the motion limiting member is configured to restrict radial movement of the proximal portion of the support structure.
  • 15. The prosthesis of claim 14, wherein the sealing member comprises a plurality of sealing elements, each sealing element being positioned at a proximal end of the support structure so as to align with a corresponding post.
  • 16. The prosthesis of claim 14, wherein the sealing member is positioned at a proximal end of the support structure and extends around the proximal end of the support structure.
  • 17. The prosthesis of claim 14, wherein the sealing member comprises a plurality of sealing tips, and wherein the sealing member is oriented so as to align each sealing tip with a corresponding post.
RELATED APPLICATION DATA

This application is a divisional of U.S. patent application Ser. No. 13/216,533, filed Aug. 24, 2011, which claims priority to U.S. Provisional Patent Application No. 61/379,115, filed Sep. 1, 2010, both of which are incorporated by reference herein in their entirety.

US Referenced Citations (580)
Number Name Date Kind
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
3795246 Sturgeon Mar 1974 A
4056854 Boretos et al. Nov 1977 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos May 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4425908 Simon Jan 1984 A
4470157 Love Sep 1984 A
4501030 Lane Feb 1985 A
4574803 Storz Mar 1986 A
4580568 Gianturco Apr 1986 A
4665906 Jervis May 1987 A
4681908 Broderick et al. Jul 1987 A
4710192 Liotta et al. Dec 1987 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4796629 Grayzel Jan 1989 A
4797901 Baykut Jan 1989 A
4819751 Shimada et al. Apr 1989 A
4834755 Silvestrini et al. May 1989 A
4856516 Hillstead Aug 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4909252 Goldberger Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922905 Strecker May 1990 A
4954126 Wallsten Sep 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5217483 Tower Jul 1993 A
5232445 Bonzel Aug 1993 A
5272909 Nguyen et al. Dec 1993 A
5295958 Shturman Mar 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum et al. Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5415633 Lazarus et al. May 1995 A
5431676 Dubrul et al. Jul 1995 A
5443446 Shturman Aug 1995 A
5449384 Johnson Sep 1995 A
5480424 Cox Jan 1996 A
5489294 McVenes et al. Feb 1996 A
5489297 Duran Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5500014 Quijano et al. Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5545209 Roberts et al. Aug 1996 A
5545211 An et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5575818 Pinchuk Nov 1996 A
5580922 Park et al. Dec 1996 A
5591195 Taheri et al. Jan 1997 A
5609626 Quijano et al. Mar 1997 A
5645559 Hachtman et al. Jul 1997 A
5665115 Cragg Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5674277 Freitag Oct 1997 A
5695498 Tower Dec 1997 A
5702368 Stevens et al. Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5746709 Rom et al. May 1998 A
5749890 Shaknovich May 1998 A
5766151 Valley et al. Jun 1998 A
5782809 Umeno et al. Jul 1998 A
5800456 Maeda et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5824041 Lenker Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824056 Rosenberg Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5843158 Lenker et al. Dec 1998 A
5851232 Lois Dec 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5861028 Angell Jan 1999 A
5876448 Thompson et al. Mar 1999 A
5891191 Stinson Apr 1999 A
5906619 Olson et al. May 1999 A
5913842 Boyd et al. Jun 1999 A
5925063 Khosravi Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5997573 Quijano et al. Dec 1999 A
6022370 Tower Feb 2000 A
6027525 Suh et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6042589 Marianne Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6042607 Williamson, IV Mar 2000 A
6051104 Jang Apr 2000 A
6059809 Amor et al. May 2000 A
6110201 Quijano et al. Aug 2000 A
6146366 Schachar Nov 2000 A
6159239 Greenhalgh Dec 2000 A
6162208 Hipps Dec 2000 A
6162245 Jayaraman Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6203550 Olson Mar 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6218662 Tchakarov et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6241757 An et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6248116 Chevilon Jun 2001 B1
6258114 Konya et al. Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6277555 Duran et al. Aug 2001 B1
6299637 Shaolia et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6309417 Spence et al. Oct 2001 B1
6338735 Stevens Jan 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350277 Kocur Feb 2002 B1
6352708 Duran et al. Mar 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371983 Lane Apr 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468303 Amplatz et al. Oct 2002 B1
6475239 Campbell et al. Nov 2002 B1
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6494909 Greenhalgh Dec 2002 B2
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6527800 McGuckin, Jr. et al. Mar 2003 B1
6530949 Konya et al. Mar 2003 B2
6530952 Vesely Mar 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562058 Seguin et al. May 2003 B2
6569196 Vesely May 2003 B1
6585758 Chouinard et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6605112 Moll et al. Aug 2003 B1
6613077 Gilligan et al. Sep 2003 B2
6622604 Chouinard et al. Sep 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6652571 White et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6656213 Solem Dec 2003 B2
6663663 Kim et al. Dec 2003 B2
6669724 Park et al. Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6673109 Cox Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6689144 Gerberding Feb 2004 B2
6689164 Seguin Feb 2004 B1
6692512 Jang Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6702851 Chinn et al. Mar 2004 B1
6719789 Cox Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730377 Wang May 2004 B2
6733525 Yang et al. May 2004 B2
6736846 Cox May 2004 B2
6752828 Thornton Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6786925 Schoon Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6792979 Konya et al. Sep 2004 B2
6797002 Spence Sep 2004 B2
6821297 Snyders Nov 2004 B2
6830575 Stenzel et al. Dec 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof Dec 2004 B1
6846325 Liddicoat Jan 2005 B2
6866650 Stevens Mar 2005 B2
6872223 Roberts Mar 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6887266 Williams et al. May 2005 B2
6890330 Streeter et al. May 2005 B2
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6913600 Valley et al. Jul 2005 B2
6929653 Streeter Aug 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6939365 Fogarty et al. Sep 2005 B1
6951571 Srivastava Oct 2005 B1
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin et al. Dec 2005 B2
6986742 Hart et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7041128 McGuckin, Jr. et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7048014 Hyodoh et al. May 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7105016 Shui et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7128759 Osborne et al. Oct 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7160319 Chouinard et al. Jan 2007 B2
7175656 Khairkhahan Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7252682 Seguin Aug 2007 B2
7300457 Palmaz Nov 2007 B2
7300463 Liddicoat Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7329278 Seguin Feb 2008 B2
7335218 Wilson et al. Feb 2008 B2
7338520 Bailey et al. Mar 2008 B2
7374571 Pease et al. May 2008 B2
7377938 Sarac et al. May 2008 B2
7381218 Shreck Jun 2008 B2
7384411 Condado Jun 2008 B1
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7462191 Spenser et al. Dec 2008 B2
7470284 Lambrecht et al. Dec 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7544206 Cohn et al. Jun 2009 B2
7547322 Sarac et al. Jun 2009 B2
7556646 Yang et al. Jul 2009 B2
7806919 Bloom et al. Oct 2010 B2
8034102 Bulman-Fleming Oct 2011 B2
20010002445 Vesely Mar 2001 A1
20010000188 Lenker et al. Apr 2001 A1
20010001314 Davison et al. May 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010011189 Drasler et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025196 Chinn et al. Sep 2001 A1
20010032013 Marton Oct 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20020010508 Chobotov Jan 2002 A1
20020029014 Jayaraman Mar 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052651 Myers et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020072789 Hackett et al. Jun 2002 A1
20020095209 Zadno-Azizi et al. Jul 2002 A1
20020099439 Schwartz et al. Jul 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020111674 Chouinard et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030028247 Cali Feb 2003 A1
20030036791 Bonhoeffer et al. Feb 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030069492 Abrams et al. Apr 2003 A1
20030109924 Cribier Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030130726 Thorpe et al. Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030139804 Hankh et al. Jul 2003 A1
20030149475 Hyodoh et al. Aug 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030212410 Stenzel et al. Nov 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030225445 Derus et al. Dec 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040082904 Houde et al. Apr 2004 A1
20040088045 Cox May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092989 Wilson et al. May 2004 A1
20040093005 Durcan May 2004 A1
20040093060 Sequin et al. May 2004 A1
20040093075 Kuehn May 2004 A1
20040097788 Mourles et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty Jun 2004 A1
20040127979 Wilson Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167573 Williamson Aug 2004 A1
20040167620 Ortiz Aug 2004 A1
20040186563 Iobbi Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040210240 Saint Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040225353 McGuckin, Jr. Nov 2004 A1
20040225354 Allen Nov 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260394 Douk Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050010246 Streeter Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto Mar 2005 A1
20050049696 Siess Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050060029 Le Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075712 Biancucci Apr 2005 A1
20050075717 Nguyen Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075724 Svanidze Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050075730 Myers Apr 2005 A1
20050075731 Artof Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050085842 Eversull et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050085890 Rasmussen et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050096568 Kato May 2005 A1
20050096692 Linder et al. May 2005 A1
20050096724 Stenzel et al. May 2005 A1
20050096734 Majercak et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113910 Paniagua May 2005 A1
20050119688 Berheim Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137686 Salahieh Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137692 Haug Jun 2005 A1
20050137695 Salahieh Jun 2005 A1
20050137701 Salahieh Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203618 Sharkawy Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050234546 Nugent Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050283962 Boudjemline Dec 2005 A1
20060004439 Spenser et al. Jan 2006 A1
20060004469 Sokel Jan 2006 A1
20060009841 McGuckin et al. Jan 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060089711 Dolan Apr 2006 A1
20060100685 Seguin et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060167474 Bloom et al. Jul 2006 A1
20060173537 Yang Aug 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060206192 Tower et al. Sep 2006 A1
20060206202 Bonhoefer et al. Sep 2006 A1
20060212111 Case et al. Sep 2006 A1
20060247763 Slater Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060276882 Case et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070010878 Raffiee et al. Jan 2007 A1
20070016286 Case et al. Jan 2007 A1
20070027518 Herrmann et al. Feb 2007 A1
20070027533 Douk Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043431 Melsheimer Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070073392 Heyninck-Janitz Mar 2007 A1
20070078509 Lotfy et al. Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070100439 Cangialosi May 2007 A1
20070100440 Figulla May 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070225681 House Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070233238 Huynh et al. Oct 2007 A1
20070238979 Huynh et al. Oct 2007 A1
20070239254 Marchand et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244544 Birdsall et al. Oct 2007 A1
20070244545 Birdsall et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255394 Ryan Nov 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070288000 Bonan Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080009940 Cribier Jan 2008 A1
20080015671 Bonhoeffer Jan 2008 A1
20080021552 Gabbay Jan 2008 A1
20080039934 Styrc Feb 2008 A1
20080048656 Tan Feb 2008 A1
20080065001 Marchand et al. Mar 2008 A1
20080065206 Liddicoat Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147105 Wilson et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080154355 Benichow et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080215143 Seguin et al. Sep 2008 A1
20080215144 Ryan et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080228263 Ryan Sep 2008 A1
20080234797 Stryc Sep 2008 A1
20080243246 Ryan et al. Oct 2008 A1
20080255651 Dwork Oct 2008 A1
20080255660 Guyenot Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080262593 Ryan et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090012600 Styrc et al. Jan 2009 A1
20090048656 Wen Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090082858 Nugent et al. Mar 2009 A1
20090085900 Weiner Apr 2009 A1
20090099653 Suri et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090164004 Cohn Jun 2009 A1
20090171447 VonSegesser et al. Jul 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20090192586 Tabor et al. Jul 2009 A1
20090192591 Ryan et al. Jul 2009 A1
20090198316 Laske et al. Aug 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216312 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090222082 Lock et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20090240320 Tuval Sep 2009 A1
20090287296 Manasse Nov 2009 A1
20100036479 Hill et al. Feb 2010 A1
20100094411 Tuval et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100161045 Righini Jun 2010 A1
20100198346 Keogh et al. Aug 2010 A1
20100234940 Dolan Sep 2010 A1
20100256723 Murray Oct 2010 A1
Foreign Referenced Citations (49)
Number Date Country
2007100074433 Aug 2007 CN
3640745 Jun 1987 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049815 Apr 2002 DE
1057460 Jun 2000 EP
1255510 Nov 2002 EP
1469797 Nov 2005 EP
2788217 Dec 1999 FR
2815844 May 2000 FR
2056023 Mar 1981 GB
2433700 Apr 2007 GB
1271508 Nov 1986 SU
WO9529640 Nov 1995 WO
WO0047136 Aug 2000 WO
WO0135870 May 2001 WO
WO0149213 Jul 2001 WO
WO0154625 Aug 2001 WO
WO0162189 Aug 2001 WO
WO0164137 Sep 2001 WO
WO0222054 Mar 2002 WO
WO0236048 May 2002 WO
WO03003943 Jan 2003 WO
WO03003949 Jan 2003 WO
WO03011195 Feb 2003 WO
WO2003047468 Jun 2003 WO
WO04019825 Mar 2004 WO
WO04089250 Oct 2004 WO
WO05002466 Jan 2005 WO
WO05004753 Jan 2005 WO
WO05046528 May 2005 WO
WO06026371 Mar 2006 WO
WO06070372 Jul 2006 WO
WO08047354 Apr 2008 WO
WO2008070797 Jun 2008 WO
WO08138584 Nov 2008 WO
WO08150529 Dec 2008 WO
WO09002548 Dec 2008 WO
WO09029199 Mar 2009 WO
WO09042196 Apr 2009 WO
WO09045338 Apr 2009 WO
WO09061389 May 2009 WO
WO09091509 Jul 2009 WO
WO09111241 Sep 2009 WO
Non-Patent Literature Citations (40)
Entry
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J. (1992) 13:704-708.
Babaliaros, et al., “State of the Art Percutaneous Intervention for the Treatment of Valvular Heart Disease: A Review of the Current Technologies and Ongoing Research in the Field of Percutaneous Heart Valve Replacement and Repair,” Cardiology 2007; 107:87-96.
Bailey, “Percutaneous Expandable Prosthetic Valves,” In: Topol EJ, ed. Textbook of Interventional Cardiology. Volume II. Second edition. WB Saunders, Philadelphia, 1994:1268-1276.
Block, et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, vol. 7 (2005) pp. 108-113.
Bonhoeffer, et al, “Percutaneous Insertion of the Pulmonary Valve,” Journal of the American College of Cardiology (United States), May 15, 2002, pp. 1664-1669.
Bonhoeffer, et al, “Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Lancet (England), Oct. 21, 2000, pp. 1403-1405.
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816.
Boudjemline, et al, “Images in Cardiovascular Medicine. Percutaneous Aortic Valve Replacement in Animals,” Circulation (United States), Mar. 16, 2004, 109, p. e161.
Boudjemline, et al, “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Mar. 2004, pp. BR61-BR66.
Boudjemline, et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Apr. 2005, pp. 831-837.
Boudjemline, et al, “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart (British Cardiac Society) (England), Dec. 2001, pp. 705-706.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study,” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Apr. 2002, pp. BR113-BR116.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal 22, Sep. 2001, p. 630.
Boudjemline, et al, “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs,” European Heart Journal (England), Jul. 2002, pp. 1045-1049.
Boudjemline, et al, “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study,” Journal of the American College of Cardiology (United States), Mar. 17, 2004, pp. 1082-1087.
Boudjemline, et al, “Percutaneous Valve Insertion: A New Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Mar. 2003, pp. 741-742.
Boudjemline, et al, “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal 22, Sep. 2001, p. 355.
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-778.
Boudjemline, et al, “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology (Ireland), 2001, pp. 89-93.
Boudjemline, et al, “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young (England), Jun. 2003, pp. 308-311.
Coats, et al, “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery (England), Apr. 2005, pp. 536-543.
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008.
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15 (2006) 123-129.
Hanzel, et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards™ percutaneous heart valve,” EuroIntervention Supplements (2006), 1 (Supplement A) A3-A8.
Huber, et al., “Do Valved Stents Compromise Coronary Flow?” Eur. J. Cardiothorac. Surg. 2004;25:754-759.
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408.
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Early and Medium Term Results,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-375.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Impact of Morphology on Case Selection,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-642-IV-643.
Lutter, et al, “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation,” The Journal of Thoracic and Cardiovascular Surgery, Apr. 2002, pp. 768-776.
Lutter, et al, “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery (Netherlands), Dec. 2004, pp. 2199-2206.
Ma, Ling, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio Thoracic Surgery, 28:194-198, 2005.
Medtech Insight, “New Frontiers in Heart Valve Disease,” vol. 7, No. 8 (2005).
Palacios, “Percutaneous Valve Replacement and Repair, Fiction or Reality?” Journal of American College of Cardiology, vol. 44, No. 8 (2004) pp. 1662-1663.
Pelton et al., “Medical Uses of Nitinol,” Materials Science Forum vols. 327-328, pp. 63-70 (2000).
Rulz, “Transcathether Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, vol. 26, No. 3 (2005).
Saliba, et al, “Treatment of Obstructions of Prosthetic Conduits by Percutaneous Implantation of Stents,” Archives des Maldies du Coeur et des Vaisseaux (France), 1999, pp. 591-596.
Webb, et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation (2006), 113;842-850.
Stassano et al., “Mid-term results of the valve-on-valve technique for bioprosthetic failure,” Eur. J. Cardiothorac. Surg. 2000; 18:453-457.
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Techol. 2000, vol. 9, pp. 287-292.
Related Publications (1)
Number Date Country
20180161158 A1 Jun 2018 US
Provisional Applications (1)
Number Date Country
61379115 Sep 2010 US
Divisions (1)
Number Date Country
Parent 13216533 Aug 2011 US
Child 15894243 US